MM+M editors Marc Iskowitz and Larry Dobrow interview people of note in and around the healthcare marketing world, and chat about news impacting the sector. New episodes to be released every Wednesday.
Roni Chase, VP of marketing at Lilly and an economist by training, explains why real world evidence (RWE) deserves to play a bigger role in pharma’s commercial strategy.
As COVID-19 vaccinations roll out and restrictions are lifted, consumers are in a state of transition that impacts mental health in many ways. In this sponsored podcast, therapist and Verywell Editor-in-Chief Amy Morin discusses how attitudes and behaviors are changing, the importance of keeping a finger on the shifts, and how health publishers can better understand and meet consumers’ needs during this long-awaited return to normalcy.
Juice Pharma’s Forrest King and Harrison and Star’s Mario Muredda and Paulette Robinson join Marc Iskowitz for the second of a four-part series exploring how MAHF member agencies are progressing toward diversity, equity and inclusion.
The COVID-19 pandemic has had a major impact on patients’ preferences and expectations when it comes to care, and it’s accelerated the move toward consumerism.
The role of work-life balance in the agency world — especially in communications/PR — is often discussed, but why should clients care and why should they seek out agency partners who place a high value on work-life balance for their own teams?
Pharmaceutical reps, patients and fellow HCPs are trying to get closer to doctors at a time when they’re driven further apart. A Q4 2020 study conducted by MM+M and RFH revealed unexpected truths for marketers that are now being released in the eBook, The Partnership Paradox.
How Splice’s embrace of individual growth and ‘creativity without walls’ underscores the agency’s employee-first culture.
How much of an impact did the pandemic have on medicine spending last year? IQVIA’s Murray Aitken joins MM+M’s Marc Iskowitz to provide a rundown on spend and usage trends, as well as the institute’s outlook for all medicine use through 2025.
Machine learning and artificial intelligence offer an unprecedented opportunity for pharmaceutical marketing to deliver differentiated messaging to precise patient and HCP audiences on the right channels at the right moment in time.
Dr. Charlotte Jones-Burton, WOCIP president and cofounder, discusses the group’s latest initiative, designed to address vaccine hesitancy among the Black and brown communities by training members of the pharma industry to “demystify” and educate on COVID-19 vaccine clinical trial data.
Heathline Media’s Brendan McHenry discusses complementary health and financial wellness as pillars of the company’s Whole Person Health Initiative.
Surveying patients for a new research report, DeepIntent found that nearly three-quarters of patients believe more lives can be saved if people were better informed about their treatment options — and that many patients don’t feel informed.
Lisa Stockman Mauriello and husband Bob Mauriello, who have been leading a high-profile campaign to gain access to Biogen’s tofersen under so-called expanded access, discuss the drugmaker’s decision this week to make the experimental ALS drug available, but not as soon as they had hoped.
Healthline Media’s Kate Gallagher presents the company’s multi-faceted Whole Person Health Initiative program.
Splice’s Jonathan Peischl discusses the company’s ‘double-sided coin’ approach to focusing on its people.
Fernando and MM+M’s Marc Iskowitz discuss the decision to pause the use of Johnson & Johnson’s COVID-19 vaccine, and what marketers can expect when the CDC meets this Friday to make recommendations for the shot’s use.
OptimizeRx’s Chris DiCostanzo and Rebecca Love explain the value of reaching patients and HCPs when it matters most.
ZocDoc founder and serial entrepreneur Cyrus Massoumi discusses his latest venture, online vaccine standby list Dr. B and where the COVID-19 vaccine rollout goes from here.
Talking Medicines’ Jo Halliday discussed how the pharmaceutical sector can better understand the voice of the patient.
Learn about Intouch Group’s journey to foster I+D so that its inclusive culture translates into inclusive healthcare marketing.